Shaping the Future of Regulatory Affairs: Trust, Technology & Transformation at the 11th GCC Regulatory Affairs Summit
The 11th GCC Regulatory Affairs Summit is set to take place in Dubai from 22-26 June 2026 at the Mövenpick Grand Al Bustan. This event will bring together over 650 industry leaders, regulators, and decision-makers to discuss the changing landscape of compliance and innovation in the region. The theme for this year's summit is "Shaping the Future of Regulatory Affairs: Trust, Technology & Transformation."
The summit will focus on key priorities in pharmaceutical regulation, including updates from regional regulatory authorities, ATMPs, vaccines, biologics, OTC standards, pharmaceutical localization, manufacturing, track and trace, and supply chain resilience. Additionally, topics such as AI in regulatory oversight, digital regulatory control, pharmacovigilance innovation, patient-centric safety, inspection readiness, pharmaceutical quality oversight, data integrity, and AI-driven quality systems will be highlighted to showcase the role of technology and operational excellence in the sector.
The event will feature three specialized conferences: the GCC Regulatory Affairs Pharma Summit on 22-23 June, the GCC Pharmacovigilance Training on 24-25 June, and the GCC Quality Conference on 26 June. A full day of hands-on eCTD Training on 25 June will also be offered, supported by eCTD Workshop Sponsor, cormeo | Docuvera – EXTEDO – Rote Liste – medicines.ie.
Dr. Mona Al Moussli, Chairman of the GCC Regulatory Affairs Summit, emphasized the summit's evolution over the past decade to align with the region's regulatory landscape. The 2026 edition aims to provide a platform for stakeholders to share knowledge, enhance collaboration, and promote regulatory excellence across the GCC.
Leading sponsors from the pharmaceutical, regulatory technology, compliance, and supply chain sectors, including CEPI, Haleon, Julphar, VISIOTT | TPS, Ipsen, Schlafender Hase, and EVOTEQ, are supporting the 2026 edition. Their participation underscores the summit's focus on regulatory excellence, patient safety, digital transformation, and compliance in the GCC pharmaceutical sector.
Dr. Najiba Al Shezawy, Co-Chairman of the GCC Regulatory Affairs Summit, highlighted the need for professionals to focus on practical implementation in response to the rapid pace of regulatory change. This year's program will facilitate discussions on regulatory challenges, digital transformation, pharmacovigilance readiness, quality expectations, and the necessary systems to enhance the resilience of the pharmaceutical sector.
With over a decade of regional engagement, the summit continues to serve as a vital platform for dialogue between regulators and industry stakeholders. Expert presentations, panel discussions, workshops, case-based learning, and networking opportunities will further support knowledge exchange and collaboration in the pharmaceutical regulatory sector.
For more information on the GCC Regulatory Affairs Summit and to access the latest agendas, please visit the official website.